iPath Long Enhanced MSCI EAFE ETN (MFLA), issued by Barclays Bank PLC, is an exchange-traded note (ETN) that provides investors with exposure to twice the daily leveraged performance of the MSCI EAFE Net Total Return Index, less fees exceeding 1.40% annually; the underlying index tracks large- and mid-cap stocks across 21 developed markets in Europe, Australasia, and the Far East, excluding the United States and Canada. Barclays Bank PLC, founded in 1690 and headquartered in London, United Kingdom, offers this ETN as part of its broader iPath series of exchange-traded notes linked to commodities, currencies, equities, and volatility indexes; the MFLA ETN trades on U.S. exchanges such as NYSE Arca and targets sophisticated investors seeking enhanced returns from international developed equity markets. In June 2025, Barclays announced the full redemption of several iPath ETNs upon exercising its issuer call option, with payments based on closing indicative note values calculated on June 17, 2025, and settlement on June 25, 2025, amid ongoing portfolio optimizations including cash tender offers, consent solicitations, and indenture amendments for multiple series; although MFLA was not explicitly named in the June redemption list, market data indicates it faces potential delisting and limited trading activity consistent with Barclays' recent ETN wind-downs. The ETN's operations span global financial markets, with Barclays serving as issuer and Barclays Capital Inc. acting as distribution agent.